Thursday, April 22, 2021

5:00 PM to 6:30 PM Eastern Time
4:00 PM to 5:30 PM Central Time
3:00 PM to 4:30 PM Mountain Time
2:00 PM to 3:30 PM Pacific Time

NOTE: You must also be registered for ONS Congress at: https://www.ons.org/store/congress-registration

*ONS will provide a restaurant gift card to the first 100 people who register and complete this symposium.

Speakers

Patricia Friend PhD, APRN-CNS, AOCNS, AGN-BC
Associate Professor and Program Director
Marcella Niehoff School of Nursing
Loyola University Chicago
Maywood, IL

Eric Zack DNP, RN, ACNP-BC, AOCN, BMTCN
RN3 (Staff/Charge Nurse) Inpatient Hematology/HSCT unit
Rush University Medical Center
Assistant Professor
Health Systems & Adult Health Nursing
Marcella Niehoff School of Nursing
Loyola University Chicago
Maywood, IL

Accredited Statement

Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 1.5 continuing education contact hour through the California Board of Registered Nursing.

Program Description

It has been 60 years since the discovery of a chromosomal abnormality in CML; the so-called Philadelphia chromosome. Since then genomics has revolutionized cancer care and the impact in hematologic malignancies is plentiful. Oncology nurses must understand the science to be able to apply in practice and communicate complex information to patients and caregivers. This session will provide an overview of foundational genomic concepts and how genomics is applied across the care continuum for hematologic cancers. Case studies examining the application of testing to “real life” situations will be presented and resources for patients will be shared.

Target Audience:

Nurses involved in the care of patients with hematologic malignancies.

Provider

The Leukemia & Lymphoma Society

Learning Objectives

At the conclusion of this program, participants will be able to:

· Discuss foundational genomic concepts (DNA, gene, chromosome, somatic and germline genomic variants)

· Discuss and define biomarkers and biomarker testing

· Identify appropriate biomarker (genomic) testing for hematologic cancers across the care continuum (diagnosis, prognosis, treatment, disease monitoring)

· Describe the role of the nurse, APRN, and others on the healthcare team in preparing patients and caregivers for biomarker testing, including access and financial implications

· Identify resources to educate and support patients and caregivers regarding biomarker testing